LINC-ROR and ovarian serous cystadenocarcinoma: We found that LIHC and ovarian serous cystadenocarcinoma showed the most markedly elevated expression of Linc-ROR in tumors compared with non-cancerous tissues among all examined cancers (Fig. 1a).